Practical methods for compensating for missed treatment days in radiotherapy, with particular reference to head and neck schedules

Clinical Oncology

Volumn 14, Issue 5, 2002, Pages 382-393

  Dale, R G ^a   Hendry, J H ^b   Jones, B ^a   Robertson, A G ^c   Deehan, C ^d   Sinclair, J A ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^d LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Cancer; Cell kinetics; Fractionation; Overall time; Radiotherapy; Time factors in radiotherapy; Treatment interruptions

Indexed keywords

ARTICLE; CANCER CONTROL; CONTROLLED STUDY; DOSIMETRY; HEAD AND NECK CANCER; HUMAN; LONG TERM CARE; MACHINE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; TUMOR GROWTH; TUMOR LOCALIZATION;

EID: 0036786713     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1053/clon.2002.0111     Document Type: Article

References (37)

1. Hendry JH, Bentzen SM, Dale RG, et al. A modelled comparison of the effect of using different ways to compensate for missed treatment days in radiotherapy. Clin Oncol 1996;8:297-307.
2. Slevin NJ, Hendry JH, Roberts SA, Agren-Cronqvist A. The effects of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy. Radiother Oncol 1992;24:215-220.
3. Fowler JF, Chappell R. Non small cell lung tumours repopulate rapidly during radiation therapy. (Letter). Int J Radiat Oncol Biol Phys 2000;46:516-517.
4. Fowler JF. Radiobiological modelling to compensate for unplanned gaps in radiation treatment. International Congress of Radiation Research, Dublin, July, 1999. In Radiation Research, Vol 2 Proceedings. Moriarty M, Mothersill C, Seymour C, Eddington M, Ward JF, Fry RJM, eds. Oak Brook, IL, U.S.A.: Int. Assoc. Rad. Res., pp. 653-659, 2000.
5. RCR Ref No BFCO (96) 4. Guidelines for the management of the unscheduled interruption or prolongation of a radical course of radiotherapy. ISBN 1 872599 26 5. 1996; Royal College of Radiologists.
6. Sinclair JA, Oates J, Dale RG. BED-time charts and their application to the problems of interruptions in external beam radiotherapy treatments. Int J Radiat Onc Biol Physics 1999; 44:381-389.
7. Wheldon TE, Barrett A. Radiobiological rationale for compensation for gaps in radiotherapy regimes by post-gap acceleration of fractionation. Br J Radial 1990;63:114-119.
8. Dale RG, Sinclair JA. A proposed Figure of Merit for the radiobiological assessment of unscheduled treatment interruptions. Br J Radiol 1994;67:1001-1007.
9. Dale RG, Jones B, Sinclair JA. Dose-equivalents of tumour repopulation during radiotherapy: the potential for confusion. Br J Radiol 2000;73:892-894.
10. Doerr W, Hendry JH. Consequential late effects in normal tissues. Radiother Oncol 2001;61:223-231.
11. Jones B, Dale RG, Deehan C, et al. The role of biologically effective dose (BED) in clinical oncology. Clin Oncol 2001;13: 71-81.
12. Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumour clonogen repopulation during radiotherapy. Acta Oncol 1988;27:131-146.
13. Fowler JF, Harari PM. Confirmation of improved loco-regional control with altered fractionation in head and neck cancer. Int J Radiat Oncol Biol Phys 2000;48:3-6.
14. Steel GG. (ed.) Basic clinical radiobiology. London: Arnold, 1997.
15. Roberts SA, Hendry JH. Time factors in larynx tumour radiotherapy: Lag times and intertumour heterogeneity in clinical datasets from four centres. Int J Radiat Oncol Biol Phys 1999;45: 1247-1257.
16. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) Phase III randomised study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000;48:7-16.
17. Withers HR, Peters LJ. Transmutability of dose and time. Comments on the 1st report of RTOG 9003 (KK Fu et al). Int J Radiat Oncol Biol Phys 2000;48:1-2.
18. Roberts SA, Hendry JA. The delay before onset of accelerated tumour cell repopulation during radiotherapy: a direct maximum-likelihood analysis of a collection of worldwide tumour-control datasets. Radiother Oncol 1993;29:69-74.
19. Allal AS, de Pree C, Dulguerov P, Bierei S, Maire D, Kurtz JM. Avoidance of treatment interruption: an unrecognised benefit of accelerated radiotherapy in oropharyngeal carcinomas? Int J Radiat Oncol Biol Phys 1999;45:41-45.
20. Robertson C, Robertson AG, Hendry JH, et al. Similar decreases in local control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. Int J Radiat Oncol Biol Phys 1998;40:319-329.
21. Robertson AG, Robertson C, Perone C, et al. Effect of gap length and position on results of treatment of cancer of the larynx in Scotland by radiotherapy: a linear quadratic analysis. Radiother. Oncol 1998;48:165-173.
22. Baumann M, Petersen C, Wolf J, Schreiber A, Zips D. No evidence for a different magnitude of the time factor for continuously fractionated irradiation and protocols including gaps in two human squamous cell carcinoma in nude mice. Radiother Oncol 2001;59:187-194.
23. Zieron JO, Omniczynski M, Raabe A, Beck-Bornholdt HP. Impact of the position of a gap on the response of the RIH-tumour of the rat on fractionated split-course radiotherapy. Strahlenther Onkol 2001;177:592-596.
24. Sanguineti G, Benasso M, Corvo R, et al. Lack of a time factor in alternating chemotherapy for advanced head and neck squamous cell carcinoma. Tumori 2001;87:10-13.
25. Weber DC, Kurtz JM, Allal AS. The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy. Int J Radiat Oncol Biol Phys 2001;50:675-680.
26. Bentzen SM, Thames HD. Overall treatment time and tumour control dose for head and neck tumours: the dog leg revisited. Radiother Oncol 1992;25:143-144.
27. Mehta M, Scrimger R, Mackie R, et al. A new approach to dose escalation in non small cell lung cancer. Int J Radiat Oncol Biol Phys 2001;49:23-33.
28. pot? Radiother Oncol 1998;46:157-167.
29. Trott KR, Kummermehr J. What is known about tumour proliferation rates to choose between accelerated fractionation or hyperfractionation? Radiother Oncol 1985;3:1-9.
30. 103 Pd. Int J Radiat Oncol Biol Phys 2000;47:1165-1167.
31. Bentzen SM, Saunders MI, Dische S. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer. Radiother Oncol 1999;53:219-226.
32. Thames HD, Hendry JH. Fractionation in radiotherapy. London: Taylor and Francis, 1987.
33. Fowler JF. Is repair of DNA strand break damage from ionizing radiation second order rather than first order? A simpler explanation of apparently multiexponential repair. Radiat Res 1999;153:124-136.
34. Dale RG, Fowler JF, Jones B. A new incomplete-repair model based on a 'reciprocal-time' pattern of sub-lethal damage repair. Acta Oncol 1999;7:919-929.
35. Dische S, Saunders MI. Continuous, hyperfractionated, accelerated radiotherapy (CHART): an interim report upon late morbidity. Radiother Oncol 1989;16:65-72.
36. Millar WT, Van den Aardweg GJ, Hopewell JW, Canney PA. Repair kinetics in pig epidermis: an analysis based on two separate rates of repair. Int J Radiat Biol 1996;69:123-140.
37. Jones B, Dale RG, Khaksar SJ. Biological equivalent dose assessment of the consequences of hypoftactionated radiotherapy. Int J Radiat Oncol Biol Phys 2000;47:1379-1384.